Consumer Willingness to Pay for POU ProductsEarly Phase 1NCT00531869
Safe Water Techniques in Kenya
A Early Phase 1 study testing biases towards products in people with Consumer Willingness to Pay for POU Products and Consumer Preferences and Use of POU Products, run by University of California, Berkeley at 1 site in Kenya.
Trial summary
Consumer preferences for POU technologies vary across consumers and products, and largely determine their adoption and subsequent usage. This is a marketing study that asks which products consumers prefer and why, and what is their willingness to pay, as understanding this is crucial to attain their widespread… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Consumer Willingness to Pay for POU Products, Consumer Preferences and Use of POU Products
- What is being tested?
- biases towards products
- Type of treatment
- Lifestyle or therapy programme
- How many people
- Not given
- Where
- 1 siteKenya
- Study dates
- May 2008to Oct 2010
- Phase
- Early Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Who may be able to join
- At least partial reliance on turbid water supply
Who cannot join
- At least partial reliance on turbid water supply
Trial locations and contacts
1 site in 1 country.
Kenya1 site, 1 recruiting
- Recruiting
Care Kenya
Kisumu
Jill Luoto, PhD ABD, 510-642-3890, mfong@haas.berkeley.edu
About this study
Official title: A Study of End-User Preferences for and Use of POU Safe Water Technologies in Kenya
Consumer preferences for POU technologies vary across consumers and products, and largely determine their adoption and subsequent usage. This is a marketing study that asks which products consumers prefer and why, and what is their willingness to pay, as understanding this is crucial to attain their widespread adoption and usage.
Read the detailed description
Visit 400 households and distribute 1 of 3 different POU technologies on randomized basis for a two-month trial. Cycle each household through trials with all 3 technologies in random order such that at the end of 6 months all households have experienced 2-month trials with each technology.
- Conditions
- Consumer Willingness to Pay for POU Products, Consumer Preferences and Use of POU Products
- Being tested
- biases towards products
- Keywords
- safewater, randomized
- Medical subject headings
- Consumer Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
biases towards productsBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
Consumer preferences and use of POU products
Secondary outcomes (1)
Consumer willingness to pay for POU products
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2007 (estimated)
- Study startMay 2008
- Primary completionMay 2010 (estimated)
- Study completionOct 2010 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Consumer Willingness to Pay for POU ProductsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Early Phase 1
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
Sponsor and investigators
- Lead sponsor
- University of California, Berkeley
- Sponsor type
- University, hospital or other
- Collaborators
- Procter and Gamble
- Investigators
- David Levine, PhD Econ, Principal investigator, UC Berkeley
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00531869
- Sponsor's protocol ID
- CPHS Protocol #2007-7-27
- Status last verified
- Jul 2008
- First submitted
- 18 Sep 2007
- Last updated
- 4 Aug 2008
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Aug 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Study of End-User Preferences for and Use of POU Safe Water Technologies in Kenya
- ClinicalTrials.gov ID
- NCT00531869
- Acronym / sponsor ID
- CPHS Protocol #2007-7-27
- Conditions
- Consumer Willingness to Pay for POU Products, Consumer Preferences and Use of POU Products
- Keywords
- safewater, randomized
- Phase
- Early Phase 1
- Study type
- Interventional
- Recruitment status
- Unknown status
- Lead sponsor
- University of California, BerkeleyUniversity, hospital or other
- Collaborators
- Procter and Gamble
- Study start
- May 2008
- Primary completion
- May 2010 (estimated)
- Study completion
- Oct 2010 (estimated)
- First posted
- 19 Sep 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Consumer preferences for POU technologies vary across consumers and products, and largely determine their adoption and subsequent usage. This is a marketing study that asks which products consumers prefer and why, and what is their willingness to pay, as understanding this is crucial to attain their widespread adoption and usage.
Detailed description
Visit 400 households and distribute 1 of 3 different POU technologies on randomized basis for a two-month trial. Cycle each household through trials with all 3 technologies in random order such that at the end of 6 months all households have experienced 2-month trials with each technology.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- At least partial reliance on turbid water supply
Key exclusion criteria (1 listed)
- At least partial reliance on turbid water supply
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| biases towards products | Behavioural | – |
Primary outcome
Consumer preferences and use of POU products
1 secondary outcome
Consumer willingness to pay for POU products
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Aug 2008.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David Levine, PhD Econ principal investigator
UC Berkeley
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Early Phase 1 study testing biases towards products in people with Consumer Willingness to Pay for POU Products and Consumer Preferences and Use of POU Products, run by University of California, Berkeley at 1 site in Kenya.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 4 Aug 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Kenya. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Jill Luoto, Phd Candidate Economics ((510) 643-5414, luoto@are.berkeley.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Consumer preferences and use of POU products. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2008.